Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001161697-21-000387)

Filing Details

Accession Number:: 0001161697-21-000387
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-17 16:53:55
Reporting Period:: 2021-08-13

Accepted Time:: 2021-08-17 16:53:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369568	Catalyst Pharmaceuticals Inc.	CPRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
929985	J Patrick Mcenany	355 Alhambra Circle, Suite 801 Coral Gables FL 33134	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-08-13	100,000	$3.12	4,911,019	No	4	M	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2021-08-13	31,186	$6.17	4,879,833	No	4	S	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2021-08-13	31,529	$6.07	4,848,304	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Disposition	2021-08-13	100,000	$0.00	100,000	$3.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,451,667		2021-08-28	No	4	M	Direct

Footnotes

Shares were sold to cover exercise price of options and tax withholding requirements.
Options vested in three annual tranches beginning on August 28, 2015.